SUMMARYFunctional imaging studies and voxel-based morphometry analysis of brain magnetic resonance imaging showed abnormalities in the hypothalamus-thalamus-orbitofrontal pathway, demonstrating altered hypocretin pathway in narcolepsy. Those distinct morphometric changes account for problems in wake-sleep control, attention and memory. It also raised the necessity to evaluate white matter changes. To investigate brain white matter alterations in drug-na€ ıve narcolepsy patients with cataplexy and to explore relationships between white matter changes and patient clinical characteristics, drug-na€ ıve narcolepsy patients with cataplexy (n = 22) and healthy age-and gender-matched controls (n = 26) were studied. Fractional anisotropy and mean diffusivity images were obtained from whole-brain diffusion tensor imaging, and tract-based spatial statistics were used to localize white matter abnormalities. Compared with controls, patients showed significant decreases in fractional anisotropy of white matter of the bilateral anterior cingulate, fronto-orbital area, frontal lobe, anterior limb of the internal capsule and corpus callosum, as well as the left anterior and medial thalamus. Patients and controls showed no differences in mean diffusivity. Among patients, mean diffusivity values of white matter in the bilateral superior frontal gyri, bilateral fronto-orbital gyri and right superior parietal gyrus were positively correlated with depressive mood. This tract-based spatial statistics study demonstrated that drug-na€ ıve patients with narcolepsy had reduced fractional anisotropy of white matter in multiple brain areas and significant relationship between increased mean diffusivity of white matter in frontal/cingulate and depression. It suggests the widespread disruption of white matter integrity and prevalent brain degeneration of frontal lobes according to a depressive symptom in narcolepsy.
IN TROD UCTI ONNarcolepsy is a disabling sleep disorder characterized by excessive daytime sleepiness (EDS) and manifestations of abnormal rapid eye movement (REM) sleep, including cataplexy, sleep paralysis, and hypnagogic or hypnopompic hallucinations (Dauvilliers et al., 2007). Besides sleep-related symptoms, regulation of emotion, cognitive impairments and mood disorder can be seen in narcolepsy (Naumann et al., 2006).Over the last two decades, numerous neuroimaging studies have investigated the pathophysiology of narcolepsy. Functional imaging studies showed metabolic (Joo et al., 2004) and perfusion (Joo et al., 2005) abnormalities in the hypothalamus-thalamus-orbitofrontal pathway and other brain areas in patients with narcolepsy, demonstrating alterations in the hypocretin pathway. Brain magnetic resonance imaging (MRI) studies in patients demonstrated distinct structural changes of multiple brain areas, accounting for problems in wake-sleep control, attention and memory ª